7/19/2019Cross-sector Synergy: China Innovation at Merck

7/18/2019Alphamab Oncology Files IPO at HKEX

7/18/2019U.S. Targeting of Chinese Scientists Fuels a Brain Drain

7/18/2019GenScript's Biologics R&D and Production Center Becomes Operation

7/18/2019State Council Issues Policy to Establish Inspection Forces for Drug Sa...

7/18/2019Snapshot of BMI System Financial Performance in Q2/2019

7/18/2019SMEI Releases Rankings of Top 100 Chinese Retail Pharmacy Chains in 20...

7/18/2019CDE Unleashes Mid-Year Report on Clinical Trial Registration with BE T...

7/17/201960% of 135 Listed Biopharma Companies Issued Positive H1 Performance G...

7/17/2019NMPA Issues New Document on Linked Evaluation and Approval of APIs, Ex...

7/17/2019China Daily: Latest Healthy China Guideline Targets Chronic Illnesses

7/17/2019X4 and Abbisko Enter Oncology Development Partnership for Mavorixafor ...

7/16/2019Swiss Agrees to Extradite Chinese Scientist to US for Corporate Espion...

7/16/2019SMEI President Reviews Pharma Industry Performance with Lowered Growth...

7/16/2019Cipla Re-enters Chinese Market in JV with Jiangsu Acebright Pharma

7/16/2019SMEI Releases Ranking of Top 100 Chinese Biopharma Companies in 2018

7/16/2019Chinese Biopharma Startups Raised $1,645M and Launched Seven IPOs in H...

7/16/2019Luye Pharma's Transdermal Patch Receives German Medical Regulatory App...

7/16/2019Trade War and China's Changing Trade Mark Law

7/15/2019CDE Issues Notice on Reference of Exemption Guidelines for Human BE St...

7/15/2019State Council Issues the Action Plan for Healthy China Initiative

7/15/2019Central Government Urges to Enhanced Basic Medical Care for Impoverish...

7/15/2019SinoMab Files IPO in Hong Kong, Making It the First Homegrown Biotech ...

7/12/2019What Is the New 'New Normal' of Chinese Pharma Going To Be?

7/12/2019Recent Executive Moves

7/12/2019Lancet: Stroke Becomes the Top Killer of Chinese Citizens

7/12/2019Review of Drug Applications Accepted for Priority Review Since Incepti...

7/12/2019Takeda Files NDA for Entyvio (Vedolizumab) in China

7/12/2019Novartis Files NDA for Second Indication of Dabrafenib/Trametinib in C...

7/11/2019Gilead Sciences to Establish Its Western China Operation Center in Che...

Page:276/777 Total number of articles:23289: [First][<<] [274] [275] [276] [277] [278] [>>] [End]